Introduction
Is the balance between nitric oxide and superoxide altered in spontaneously hypertensive rats with endothelial dysfunction?
Nitrosative stress by cyclosporin A in the endothelium
Effects of nitric oxide synthase blockers on renal function
Effects of loop diuretics on angiotensin II-stimulated vascular smooth muscle cell growth
The loop diuretic torasemide interferes with endothelin-1 actions in the aorta of hypertensive rats
Pathways of angiotensin-(1–7) metabolism in the kidney
Angiotensin II activates nuclear transcription factor-κB in aorta of normal rats and in vascular smooth muscle cells of AT1 knockout mice
Up-regulation of endoglin, a TGF-β-binding protein, in rats with experimental renal fibrosis induced by renal mass reduction
Atorvastatin prevents glomerulosclerosis and renal endothelial dysfunction in hypercholesterolaemic rabbits
Angiotensin II AT1 receptor antagonists and platelet activation
The kidney in arterial hypertension
Renal dopaminergic mechanisms in renal parenchymal diseases and hypertension
The role of nitric oxide in hypertension and renal disease progression
Role of hypertension in the progression of chronic renal disease
Sympathetic overactivity and arterial hypertension in renal failure
Prevalence of hypertension in renal disease
Clinical characteristics of ischaemic renal disease
Effect of strict blood pressure control on proteinuria in renal patients treated with different antihypertensive drugs
Effect of angiotensin II receptor blockade on renal disease progression in patients with non-diabetic chronic renal failure
Losartan reduces microalbuminuria in hypertensive microalbuminuric type 2 diabetics
Effect of losartan on TGF-β1 and urinary albumin excretion in patients with type 2 diabetes mellitus and microalbuminuria
Blood pressure and body water distribution in chronic renal failure patients
Haemodialysis dose, extracellular volume control and arterial hypertension
Anaemia, renal insufficiency and cardiovascular outcome
Hypertension and long-term renal allograft survival
Ambulatory blood pressure after renal transplantation
Role of transforming growth factor-β1 in the progression of chronic allograft nephropathy
Angiotensin II type 1 (AT1) receptor antagonists in the treatment of hypertension after renal transplantation
Influence of cyclosporin, tacrolimus and rapamycin on renal function and arterial hypertension after renal transplantation